An Australian Patent Opposition, Revocation and Extension of Term Round-Up from the Patent Office Journal dated 21 June 2012.
Opposition Proceedings
Opposition Lodged
No new oppositions to acceptance have been filed as at 21 June 2012.
Opposition Withdrawn
Opposition to acceptance of the following applications has been withdrawn as at 21 June 2012:
| Application No. | Applicant(s) | Opponent(s) |
| 2003203773 | ANSAC Pty Ltd | Wesfarmers Char Pty Ltd |
| 2005207096 | DE Technologies Limited | Securency International Pty Ltd |
| 2007234313 | Bioteq Environmental Technologies Inc. | Paques IP B.V. |
Applications Withdrawn
No additional applications have been withdrawn following opposition as at 21 June 2012.
Extensions of Term of Standard Patents
The following application(s) for Extension of Term have been granted under Section 74:
| Patent No. | Patentee(s) | Goods & New expiry date |
| 657706 | Alkermes Pharma Ireland Ltd. | FAM YRA fampridine
New expiry date 1 November 2016 |
Surrendered and Revoked Letters Patent
Surrender Letters Patent
The following patents have been offered for surrender as at 21 June 2012:
| Patent No. | Patentee(s) | Patent Date | Title |
| 716747 | CSL Limited | 15 June 2000 | Stabilised growth hormone formulation and method of preparation thereof |
| 779581 | H. Lundbeck A/S | 26 May 2005 | Process for the preparation of 5-carboxyphthalide and its use for the production of citalopram |
Revocation of Patent
The following patents have been revoked under Section 138 as at 21 June 2012:
| Patent No. | Patentee(s) | Patent Date | Court Order |
| 715655 | Sanofi-Aventis | 17 February 1997 | Federal Court of Australia, No. NSD612/2012; Court Order dated 29 May 2012 |